---
figid: PMC3217209__nihms332798f1
figlink: /pmc/articles/PMC3217209/figure/F1/
number: Figure 1
caption: In early-mid-stage atherosclerotic lesions, insulin resistance is associated
  with a decrease in eNOS activation and NO production and increase in VCAM-1 expression
  by arterial ECs. Both of these perturbations may be due to down-regulation of the
  insulin receptor-Akt1 pathway in ECs. The net effect is endothelial dysfunction
  and activation, leading to defective vasodilation and increased entry of inflammatory
  cells into the plaque. Inset, summary scheme of canonical insulin receptor signaling
  pathway; see text for details.
pmcid: PMC3217209
papertitle: Insulin Resistance, Hyperglycemia, and Atherosclerosis.
reftext: Karin E. Bornfeldt, et al. Cell Metab. ;14(5):575-585.
pmc_ranked_result_index: '91244'
pathway_score: 0.9490337
filename: nihms332798f1.jpg
figtitle: Insulin Resistance, Hyperglycemia, and Atherosclerosis
year: ''
organisms: Homo sapiens
ndex: c824eb82-deae-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3217209__nihms332798f1.html
  '@type': Dataset
  description: In early-mid-stage atherosclerotic lesions, insulin resistance is associated
    with a decrease in eNOS activation and NO production and increase in VCAM-1 expression
    by arterial ECs. Both of these perturbations may be due to down-regulation of
    the insulin receptor-Akt1 pathway in ECs. The net effect is endothelial dysfunction
    and activation, leading to defective vasodilation and increased entry of inflammatory
    cells into the plaque. Inset, summary scheme of canonical insulin receptor signaling
    pathway; see text for details.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - MAPK3
  - MAPK1
  - CXCL6
  - AKT2
  - AKT1
  - NOS3
  - CXCL13
  - FOXO4
  - CXCL11
  - GSK3A
  - CXCL10
  - AKT3
  - PF4
  - CXCL8
  - PPBP
  - FOXO3
  - CXCL12
  - CXCL5
  - CXCL14
  - CXCL9
  - PIR
  - CXCL3
  - FOXO1
  - VCAM1
  - MTOR
  - PDK4
  - FOXO6
  - GSK3B
  - PDK1
  - CXCL1
  - CXCL2
  - APOB
  - PDK3
  - PDK2
  - Cancer
genes:
- word: Lps
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: ?â†‘ERK-1/2activation
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK-1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: p-AKT1
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: p-IR
  symbol: PIR
  source: hgnc_symbol
  hgnc_symbol: PIR
  entrez: '8544'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: VCAM-1
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p-PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: p-FoxO,p-GSK3,p-mTOR,others
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: p-PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: apoB
  symbol: APOB
  source: hgnc_symbol
  hgnc_symbol: APOB
  entrez: '338'
- word: p-PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: p-PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
